According to Kiniksa Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -HK$0.15 B. In 2023 the company made an earning of -HK$0.13 B a decrease over its 2022 earnings that were of HK$85.67 M.The earnings displayed on this page is the company's Pretax Income.